Zhiqiang Liu Ph.D.

Zhiqiang Liu Ph.D.

Patterson Belknap Webb & Tyler LLP

Contact
View Bio
RSS

Latest Posts › Biologics

Share:

Q2 2019 Review: Biosimilar IPRs See a Drop in New Filings and Mixed Results

At the end of 2017, inter partes review (IPR) proceedings for biosimilar products were on the rise. 2018 and the first half of 2019, however, have seen a dip in the number of new filings. And looking back at biosimilar IPRs...more

7/25/2019  /  Biologics , Biosimilars , Inter Partes Review (IPR) Proceeding , Patent Litigation , Patent Trial and Appeal Board , Patents , Pharmaceutical Industry , Pharmaceutical Patents
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide